Intentional CYP3A4 inhibition in venetoclax-based AML therapy: from incidental observation to validated clinical strategy.
Saved in:
| Title: | Intentional CYP3A4 inhibition in venetoclax-based AML therapy: from incidental observation to validated clinical strategy. |
|---|---|
| Authors: | De la Garza-Salazar, Fernando1 (AUTHOR) fernandodelagarza@gmail.com |
| Source: | Leukemia & Lymphoma. Jun2026, p1-3. 3p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
